Join Growin Stock Community!

訊聯智藥7808.TW Overview

TW StockBiotech. & Medical
(No presentation for 7808)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

訊聯智藥（7808）Overall Performance

訊聯智藥（7808）AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

訊聯智藥（7808） PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

訊聯智藥（7808）Key Information

訊聯智藥（7808）Profile

訊聯智藥（7808）FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

No related data records

default symbol

7808

訊聯智藥

49.50D

-1.01%

(-0.01)

  • When is 7808's latest earnings report released?

    The most recent financial report for 訊聯智藥 (7808) covers the period of 2025Q2 and was published on 2025/06/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 7808's short-term business performance and financial health. For the latest updates on 7808's earnings releases, visit this page regularly.

  • How much cash does 7808 have?

    At the end of the period, 訊聯智藥 (7808) held Total Cash and Cash Equivalents of 19.75M, accounting for 0.02 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does 7808 go with three margins increasing?

    In the latest report, 訊聯智藥 (7808) did not achieve the “three margins increasing” benchmark, with a gross margin of 31.76%%, operating margin of -85.68%%, and net margin of -71.33%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 7808's profit trajectory and future growth potential.